Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Your favorite beauty brands are now also entertainment brands
Many of today’s beauty brands are asking if entertainment and advertising can be one and the same.
Synthetic data specialist Ideally wants research to be used at the start of the creative process
Ideally is looking to reinvent research when serving the creative side of the industry by integrating consumer insights earlier in the creative process.
By the numbers: How marketers are building the infrastructure for AI search
Marketers are carving out budgets for AI search, but research suggests execution, measurement and content strategies are still catching up.